Diabetic wound. Type 2 diabetes mellitus with other skin ulcer
Conditions
Interventions
Intervention 1: Smart nanofiber wound dressing containing 1% Melissa officinalis extract:Patients in the intervention group will use a smart nanofiber wound dressing containing 1% Melissa officinalis
Sponsors
Pajoohesh BAMA Co
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with diabetic wounds Participants aged between 18 and 80 years Participants who demonstrate adequate compliance with the use of the wound dressing throughout the treatment period Participants who have provided written informed consent prior to enrollment
Exclusion criteria
Exclusion criteria: Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome variable is wound healing, measured as the reduction in wound area in patients treated with the smart nano-wound dressing. Wound area will be assessed using graph paper measurement or digital imaging software at specified time points. Changes in wound area between the treatment and control groups will be compared as the main indicator of study efficacy. Timepoint: Assessments will be conducted on days 0, 7, 14, and 28, with the schedule extended as needed until complete wound healing. Method of measurement: Wound evaluation will be performed through visual inspection and by measuring the wound surface area. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ghazaleh Chizari Fard
Pajooshesh BAMA Co.
Outcome results
None listed